IFNG and neoplasm: PD‐1 initiates immunosuppressive signalling by binding to its ligand, PD‐L1, that is expressed on multiple cell types in the tumor microenvironment including tumor cells,23 and is upregulated in response to IFN‐γ secreted by activated T cells.24